Immunic (IMUX) Retained Earnings (2013 - 2026)
Immunic (IMUX) reported Retained Earnings of -$641.2 million for Q1 2026, down 19.42% on a YoY basis from -$795.7 million in Q1 2025, and down 5.35% sequentially from -$608.6 million in Q4 2025.
Immunic (IMUX) Retained Earnings (2013 - 2026) Analysis & Trends
Immunic (IMUX) has 14 years of Retained Earnings data on file, last reported at -$641.2 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 19.42% year-over-year to -$641.2 million; the trailing twelve-month figure through Mar 2026 stood at -$641.2 million (down 19.42% YoY), and the FY2025 full-year result was -$608.6 million, down 19.01% from the prior year.
- Retained Earnings eased to -$641.2 million in Q1 2026, from -$608.6 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $430.0 million in Q1 2023 to a low of -$641.2 million in Q1 2026.
- A 5-year average of -$287.8 million and a median of -$366.6 million in 2023 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings sank 32500.0% in 2022 and surged 138795.16% in 2023, its largest moves.
- Tracing IMUX's Retained Earnings over 5 years: stood at -$317.3 million in 2022, then retreated by 29.51% to -$410.9 million in 2023, then slipped by 24.46% to -$511.4 million in 2024, then dropped by 19.01% to -$608.6 million in 2025, then decreased by 5.35% to -$641.2 million in 2026.
- Business Quant data shows IMUX's Retained Earnings at -$641.2 million in Q1 2026, -$608.6 million in Q4 2025, and -$589.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Immunic | 11.03 Mn | 11.03 Mn | - | -641.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -641.16 Mn |
| Dec 31, 2025 | -608.60 Mn |
| Sep 30, 2025 | -589.30 Mn |
| Jun 30, 2025 | 2.53 Mn |
| Mar 31, 2025 | -536.87 Mn |
| Dec 31, 2024 | -511.40 Mn |
| Sep 30, 2024 | 3.89 Mn |
| Jun 30, 2024 | -461.90 Mn |
| Mar 31, 2024 | 4.29 Mn |
| Dec 31, 2023 | -410.90 Mn |
| Sep 30, 2023 | -389.30 Mn |
| Jun 30, 2023 | -366.55 Mn |
| Mar 31, 2023 | 429.96 Mn |
| Dec 31, 2022 | -317.28 Mn |
| Sep 30, 2022 | -260.80 Mn |
| Jun 30, 2022 | -239.58 Mn |
| Mar 31, 2022 | -310,000.00 |
| Dec 31, 2021 | -196.87 Mn |
| Sep 30, 2021 | -800,000.00 |
| Jun 30, 2021 | 278.53 Mn |